indomethacin has been researched along with Carcinoma, Pancreatic Ductal in 2 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Indomethacin treated Panc-1 cells were analyzed with Raman spectroscopy, quantitative polymerase chain reaction and immunofluorescence techniques after the induction of EMT with TGF-β." | 1.72 | Indomethacin prevents TGF-β-induced epithelial-to-mesenchymal transition in pancreatic cancer cells; evidence by Raman spectroscopy. ( Çamdal, A; Ciftci, Z; Inal, A; Onses, MS; Sahin, F; Sakir, M; Sezer, G; Sezer, Z, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sezer, G | 1 |
| Onses, MS | 1 |
| Sakir, M | 1 |
| Sahin, F | 1 |
| Çamdal, A | 1 |
| Sezer, Z | 1 |
| Inal, A | 1 |
| Ciftci, Z | 1 |
| Sun, L | 1 |
| Chen, K | 1 |
| Jiang, Z | 1 |
| Chen, X | 1 |
| Ma, J | 1 |
| Ma, Q | 1 |
| Duan, W | 1 |
2 other studies available for indomethacin and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Indomethacin prevents TGF-β-induced epithelial-to-mesenchymal transition in pancreatic cancer cells; evidence by Raman spectroscopy.
Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Hu | 2022 |
Indometacin inhibits the proliferation and activation of human pancreatic stellate cells through the downregulation of COX-2.
Topics: Carcinoma, Pancreatic Ductal; Cell Movement; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Cy | 2018 |